NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its third-quarter revenues increased nearly 2 percent, but were up 5 percent on a currency-neutral basis.

The Franklin Lakes, NJ-based medical devices, diagnostics, and research products firm generated total revenues of $1.98 billion for the quarter ended June 30, compared to $1.95 billion for the third quarter of 2011. It missed analysts' consensus estimate of $2.02 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.